CPIM
IRMD icon

Columbia Partners Investment Management’s iRadimed IRMD Stock Holding History

Columbia Partners Investment Management’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-120,766
Closed -$3.38M – 345
2015
Q4 		$3.38M Buy
+120,766
New +$3.41M 0.23% 125

Other funds holding IRMD

CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
CM
Castleark Management Chicago, Illinois $3.02B AUM 53.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
RFC
Russell Frank Company Seattle, Washington $56.9B AUM 2.13% 1-Year Est. Return
TCM
Timpani Capital Management Milwaukee, Wisconsin $209M AUM 62.15% 1-Year Est. Return
AR
Advisory Research Chicago, Illinois $813M AUM 36.71% 1-Year Est. Return
MCM
McKinley Capital Management Anchorage, Alaska $571M AUM 36.44% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

Columbia Partners Investment Management's IRMD Position: Q1 2016 in Review

Columbia Partners Investment Management sold out of iRadimed (IRMD) in Q1 2016, closing a stake of 120,766 shares — an estimated $3.38M sold.

Columbia Partners Investment Management first reported a position in IRMD in Q4 2015 and held it in 1 quarter. The position peaked at $3.38M in Q4 2015. 66 funds tracked by Wall St. Rank hold IRMD as of Q1 2016.

  • Columbia Partners Investment Management reported no remaining iRadimed position as of Q1 2016 after selling out during the quarter.
  • Columbia Partners Investment Management sold 120,766 iRadimed shares in Q1 2016, an estimated $3.38M.
  • Columbia Partners Investment Management first reported a position in iRadimed in Q4 2015 and held it in 1 quarter.
  • Columbia Partners Investment Management's iRadimed position peaked at $3.38M in Q4 2015.
  • 66 funds tracked by Wall St. Rank held iRadimed as of Q1 2016.

Based on Columbia Partners Investment Management's 13F filing for Q1 2016, filed 10 May 2016.